PptT Protein Targeting for Mycobacterial Lipid Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The biosynthesis of unique lipids in Mycobacterium tuberculosis, essential for its pathogenicity and resistance, relies on specific posttranslational modifications by 4'-phosphopantetheinyl transferases (PPTases), but the roles and redundancy of the identified PPTases in mycobacteria are not fully understood, limiting the development of targeted antimycobacterial drugs.
Innovation Solution
The PptT protein, a Sfp-type PPTase, is identified as essential for activating type-I polyketide synthases and other enzymes involved in lipid virulence factor biosynthesis, and is proposed as a target for screening compounds with antibiotic activity, using an in vitro screening process involving Pks proteins and labeled Acetyl-CoA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If multiple PPTases are identified in mycobacteria, then the complexity of lipid biosynthesis is increased, but the understanding of their specific roles and redundancy remains insufficient
Solution Approach 1:
The patent segments the PPTase population into distinct functional groups (AcpS-type and Sfp-type) with different substrate specificities. AcpS-type PPTases specifically activate ACP domains of type-II Fas and Pks systems, while Sfp-type PPTases activate ACP domains of type-I Fas and Pks systems. This segmentation allows systematic investigation of each PPTase's unique role in lipid biosynthesis pathways.
Solution Approach 2:
The patent uses substrate-specificity as an intermediary characteristic to distinguish between PPTase functions. By measuring which ACP substrates each PPTase activates, the study creates a mapping that reveals the specific biochemical roles of each enzyme, transforming the complex mixture of PPTases into identifiable functional units.
2Reliability
If PPTases are targeted for antibiotic development, then new antimycobacterial drugs can be developed, but the incomplete understanding of PPTase redundancy limits drug design
Solution Approach 1:
The patent employs genetic deletion strategies as a feedback mechanism to test PPTase essentiality. By deleting specific PPTase genes (e.g., ΔacpS, ΔpptT) and observing the phenotypic consequences on cell growth and lipid biosynthesis, the study determines which PPTases are essential for viability and which can be compensated by redundant enzymes.
Solution Approach 2:
The patent changes the functional parameter of PPTase activity by comparing wild-type and deletion mutant strains. The study measures parameters such as cell growth rate, lipid composition, and enzyme activation levels to determine the impact of PPTase loss, thereby identifying reliable drug targets among the PPTase family.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PptT protein's role in activating critical enzymes for lipid biosynthesis in mycobacteria makes it a promising target for developing new antimycobacterial drugs, with the screening process effectively measuring antibiotic activity and potential drug efficacy.
Implementation Method 1
4'-phosphopantetheinyl transferase (PPTase), which transfers the P-pant group from coenzyme A (CoA) to the ACP
Data Source
Figure 1A~1C
Figure 2A~2B
Figure 3A~3C
AI summary
The present invention pertains to the use of a PptT protein, as a target for screening compounds for identifying those having an antibiotic activity, especially against a pathogenic bacterium containing mycolic acids. The invention also concerns an in vitro screening process for identifying compounds having an antibiotic activity, by measuring the activity of a PptT protein in the presence or absence of said compounds.